Abstract:The onset of obesity-linked type 2 diabetes (T2D) is marked by an eventual failure in pancreatic β-cell function and mass that is no longer able to compensate for the inherent insulin resistance and increased metabolic load intrinsic to obesity. However, in a commonly used model of T2D, the db/db mouse, β-cells have an inbuilt adaptive flexibility enabling them to effectively adjust insulin production rates relative to the metabolic demand. Pancreatic β-cells from these animals have markedly reduced intracellular insulin stores, yet high rates of (pro)insulin secretion, together with a substantial increase in proinsulin biosynthesis highlighted by expanded rough endoplasmic reticulum and Golgi apparatus. However, when the metabolic overload and/or hyperglycemia is normalized, β-cells from db/db mice quickly restore their insulin stores and normalize secretory function. This demonstrates the β-cell's adaptive flexibility and indicates that therapeutic approaches applied to encourage β-cell rest are capable of restoring endogenous β-cell function. However, mechanisms that regulate β-cell adaptive flexibility are essentially unknown. To gain deeper mechanistic insight into the molecular events underlying β-cell adaptive flexibility in db/db β-cells, we conducted a combined proteomic and post-translational modification specific proteomic (PTMomics) approach on islets from db/db mice and wild-type controls (WT) with or without prior exposure to normal glucose levels. We identified differential modifications of proteins involved in redox homeostasis, protein refolding, K48-linked deubiquitination, mRNA/protein export, focal adhesion, ERK1/2 signaling, and renin-angiotensin-aldosterone signaling, as well as sialyltransferase activity, associated with β-cell adaptive flexibility. These proteins are all related to proinsulin biosynthesis and processing, maturation of insulin secretory granules, and vesicular trafficking-core pathways involved in the adaptation of insulin production to meet metabolic demand. Collectively, this study outlines a novel and comprehensive global PTMome signaling map that highlights important molecular mechanisms related to the adaptive flexibility of β-cell function, providing improved insight into disease pathogenesis of T2D.

Cytokines in the Progression of Pancreaticβ-Cell Dysfunction

Transcriptional Control of Pancreatic Β-Cell Identity and Plasticity During the Pathogenesis of Type 2 Diabetes.

Β-Cell Dynamics in Type 2 Diabetes and in Dietary and Exercise Interventions

Molecular Mechanism of Islet Β-Cell Functional Alternations During Type 2 Diabetes.

Pancreatic Beta-cell Dysfunction in Type 2 Diabetes

Pancreatic -cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

Comments on ‘dietary Intervention Preserves Β Cell Function in Mice Through CTCF-mediated Transcriptional Reprogramming’

Therapeutic opportunities for pancreatic β-cell ER stress in diabetes mellitus

Interferons are key cytokines acting on pancreatic islets in type 1 diabetes

Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes

A Multi-Method Evaluation Of The Effects Of Inflammatory Cytokines (Il-1 Beta, Ifn-Gamma, Tnf-Alpha) On Pancreatic Beta-Cells

The role of insulin signaling in the development of β-cell dysfunction and diabetes

Beta Cell Physiological Dynamics and Dysfunctional Transitions in Response to Islet Inflammation in Obesity and Diabetes

IL-1β Signaling and β Cell Function

Pancreatic β-cells in type 1 and type 2 diabetes mellitus: different pathways to failure

Altered Plasma Profile of Antioxidant Proteins as an Early Correlate of Pancreatic β Cell Dysfunction

To Be or Not to Be: The Divergent Action and Metabolism of Sphingosine-1 Phosphate in Pancreatic Beta-Cells in Response to Cytokines and Fatty Acids

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice

Metabolic Stress and Compromised Identity of Pancreatic Beta Cells

The Dynamics Mechanism of Islet Inflammation During Type 2 Diabetes Progress

Role of pancreatic-derived factor in type 2 diabetes: evidence from pancreatic β cells and liver.